sotigalimab,paclitaxel,pembrolizumab,nivolumab,177lu-psma-617
novartis,bms,merck
['177lu,psma,617', 'prince', 'crpc', 'pembro']
circulating tumor cells and psma pet correlates in the phase i #prince trial of 177lu-psma-617 + pembrolizumab for #mcrpc. presentation by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology